Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,39 USD | -0,62% | +23,60% | +334,69% |
Attività
Numero di dipendenti: 42
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 01/09/20 |
Founder | 66 | 01/01/02 | |
Charles Schoch
DFI | Director of Finance/CFO | 39 | - |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 57 | 02/03/22 |
Francesca Barone
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/11/20 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 55 | 12/09/22 |
Ileen B. Winick
HRO | Human Resources Officer | - | 01/01/21 |
Nathan Caffo
PRN | Corporate Officer/Principal | 55 | 01/09/20 |
Susan Stewart
LAW | General Counsel | 64 | 01/10/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 68 | 08/08/22 |
Edward Benz
BRD | Director/Board Member | 78 | 01/09/17 |
Paul Manning
CHM | Chairman | 68 | 01/11/18 |
Gary Nabel
BRD | Director/Board Member | 70 | 08/08/22 |
Founder | 66 | 01/01/02 | |
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 01/09/20 |
Renee Gaeta
BRD | Director/Board Member | 42 | 08/08/22 |
Diem Nguyen
BRD | Director/Board Member | 52 | 15/07/21 |
Director/Board Member | 45 | 01/11/18 | |
Nicoletta Loggia
BRD | Director/Board Member | - | 07/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 29 470 076 | 19 157 342 ( 65,01 %) | 0 | 65,01 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+334,69% | 188 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione CADL
- Società Candel Therapeutics, Inc.